Cereno Scientific's Capital Markets Day, 17th of October, 2024, at Posthuset in Stockholm.

00:00:00 Welcome
00:00:31 Introduction to Cereno Scientific
00:11:30 Understanding PAH, a debilitating rare disease
00:31:10 Cereno Scientific’s CS1 in PAH
00:38:03 Cereno Scientific’s CS1 - Phase IIa trial results
01:06:35 Investigator and patient perspective of CS1-003 trial
01:16:24 Next steps for CS1
01:20:10 Introduction to Fluidda and the innovative Functional Respiratory Imaging technology
01:39:07 CS014 targeting unmet needs in rare disease IPF
01:53:58 CS585 being evaluated in rare diseases
02:11:52 Cereno Scientific - strategic focus and future outlook
02:26:05 Questions from Audience on site and online
02:46:25 Concluding remarks